Valproate-Induced Metabolic Syndrome-Reference-Cited by-同舟云学术

Valproate-Induced Metabolic Syndrome

Published:2023-05-22 Issue:5 Volume:11 Page:1499
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Shnayder Natalia A.¹²^ORCID,Grechkina Violetta V.¹^ORCID,Trefilova Vera V.¹³,Efremov Ilya S.⁴,Dontceva Evgenia A.²⁵,Narodova Ekaterina A.²^ORCID,Petrova Marina M.²,Soloveva Irina A.²,Tepnadze Liia E.²,Reznichenko Polina A.²,Al-Zamil Mustafa⁶^ORCID,Altynbekova Gulnara I.⁷,Strelnik Anna I.⁸^ORCID,Nasyrova Regina F.¹⁸^ORCID

Affiliation:

1. Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia

2. Shared Core Facilities “Molecular and Cell Technologies”, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia

3. Department of Neurology, Hospital for War Veterans, 193079 Saint Petersburg, Russia

4. Department of Psychiatry and Narcology, Bashkir State Medical University, 450008 Ufa, Russia

5. Federal Centre for Neurosurgery, 630087 Novosibirsk, Russia

6. Department of Physiotherapy, Faculty of Continuing Medical Education, Peoples’ Friendship University of Russia, 117198 Moscow, Russia

7. Department of Psychiatry and Narcology, S.D. Asfendiarov Kazakh National Medical University, Almaty 050022, Kazakhstan

8. International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, 443016 Samara, Russia

Abstract

Valproic acid (VPA) and its salts (sodium calcium magnesium and orotic) are psychotropic drugs that are widely used in neurology and psychiatry. The long-term use of VPA increases the risk of developing adverse drug reactions (ADRs), among which metabolic syndrome (MetS) plays a special role. MetS belongs to a cluster of metabolic conditions such as abdominal obesity, high blood pressure, high blood glucose, high serum triglycerides, and low serum high-density lipoprotein. Valproate-induced MetS (VPA-MetS) is a common ADR that needs an updated multidisciplinary approach to its prevention and diagnosis. In this review, we consider the results of studies of blood (serum and plasma) and the urinary biomarkers of VPA-MetS. These metabolic biomarkers may provide the key to the development of a new multidisciplinary personalized strategy for the prevention and diagnosis of VPA-MetS in patients with neurological diseases, psychiatric disorders, and addiction diseases.

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Link

https://www.mdpi.com/2227-9059/11/5/1499/pdf

Reference213 articles.

1. Metabolic syndrome and peripheral neuropathy;Kazamel;Muscle Nerve,2021

2. Oye-Somefun, A., Kuk, J.L., and Ardern, C.I. (2021). Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: Analysis of the U.S. National Health and Nutrition Examination Survey (NHANES). BMC Cardiovasc. Disord., 21.

3. Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack with Metabolic Syndrome and/or Diabetes Mellitus;Chen;J. Am. Heart Assoc.,2017

4. Metabolic syndrome in psychiatric patients: Overview, mechanisms, and implications;Penninx;Dialogues Clin. Neurosci.,2018

5. Khasanova, A.K., Dobrodeeva, V.S., Shnayder, N.A., Petrova, M.M., Pronina, E.A., Bochanova, E.N., Lareva, N.V., Garganeeva, N.P., Smirnova, D.A., and Nasyrova, R.F. (2022). Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome. Metabolites, 12.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid;Safety and Risk of Pharmacotherapy;2023-10-26